HomeCompareOGZPY vs MRK

OGZPY vs MRK: Dividend Comparison 2026

OGZPY yields 405.02% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OGZPY wins by $198680497015448.34M in total portfolio value
10 years
OGZPY
OGZPY
● Live price
405.02%
Share price
$1.10
Annual div
$4.46
5Y div CAGR
60.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$198680497015448.41M
Annual income
$197,849,047,843,232,020,000.00
Full OGZPY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — OGZPY vs MRK

📍 OGZPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOGZPYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OGZPY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OGZPY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OGZPY
Annual income on $10K today (after 15% tax)
$34,426.63/yr
After 10yr DRIP, annual income (after tax)
$168,171,690,666,747,200,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, OGZPY beats the other by $168,171,690,666,747,200,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OGZPY + MRK for your $10,000?

OGZPY: 50%MRK: 50%
100% MRK50/50100% OGZPY
Portfolio after 10yr
$99340248507724.23M
Annual income
$98,924,523,921,616,010,000.00/yr
Blended yield
99.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OGZPY
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OGZPY buys
0
MRK buys
0
No recent congressional trades found for OGZPY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOGZPYMRK
Forward yield405.02%2.76%
Annual dividend / share$4.46$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60.8%32.7%
Portfolio after 10y$198680497015448.41M$56.8K
Annual income after 10y$197,849,047,843,232,020,000.00$9,798.13
Total dividends collected$198625781270238.69M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OGZPY vs MRK ($10,000, DRIP)

YearOGZPY PortfolioOGZPY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$75,827$65,127.08$11,206$366.19+$64.6KOGZPY
2$823,279$742,144.14$12,650$502.35+$810.6KOGZPY
3$12,990,048$12,109,139.14$14,407$694.19+$12.98MOGZPY
4$301,029,757$287,130,406.32$16,585$967.82+$301.01MOGZPY
5$10,321,644,374$9,999,542,533.13$19,342$1,363.89+$10321.63MOGZPY
6$526,298,740,485$515,254,581,005.12$22,913$1,947.19+$526298.72MOGZPY
7$40,045,905,426,803$39,482,765,774,484.11$27,662$2,823.89+$40045905.40MOGZPY
8$4,557,619,018,376,624$4,514,769,899,569,945.00$34,159$4,173.35+$4557619018.34MOGZPY
9$777,055,301,136,820,400$772,178,648,787,157,500.00$43,337$6,308.80+$777055301136.78MOGZPY
10$198,680,497,015,448,400,000$197,849,047,843,232,020,000.00$56,776$9,798.13+$198680497015448.34MOGZPY

OGZPY vs MRK: Complete Analysis 2026

OGZPYStock

Public Joint Stock Company Gazprom, an integrated energy company, engages in the geological exploration, production, processing, storage, transportation, and sale of gas, gas condensates, and oil in Russia and internationally. The company operates through Production of Gas, Transportation of Gas, Distribution of Gas, Gas Storage, Production of Crude Oil and Gas Condensate, Refining, and Electric and Heat Energy Generation and Sales segments. It also produces coalbed methane; and owns Unified Gas Supply System, a gas transmission system totaling approximately 175.2 kilometers that comprises 254 compressor stations with a total capacity of 46.8 megawatts in Russia. In addition, the company operates underground gas storage facilities; operates oil refining and petrochemical complexes; generates and sells electric and heat energy; produces crude oil and gas condensate; and produces other goods, as well as provides other works and rendering of other services. Further, it offers oil, gas condensate, and other hydrocarbons; and sells refined products. Public Joint Stock Company Gazprom was founded in 1993 and is headquartered in Moscow, Russia.

Full OGZPY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this OGZPY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OGZPY vs SCHDOGZPY vs JEPIOGZPY vs OOGZPY vs KOOGZPY vs MAINOGZPY vs JNJOGZPY vs ABBVOGZPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.